Resources from the same session
Introduction by the chair
Presenter: Marianne Pavel
Session: What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?
Resources:
Slides
Webcast
177Lu-dotatate
Presenter: Eric Baudin
Session: What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?
Resources:
Slides
Webcast
Hepatic arterial embolization
Presenter: Jonathan Strosberg
Session: What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Marianne Pavel
Session: What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?
Resources:
Slides
Webcast